ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 219 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,867,682 | +70.0% | 40,991 | +53.7% | 0.00% | 0.0% |
Q1 2024 | $2,862,975 | +9.1% | 26,677 | +1.4% | 0.00% | 0.0% |
Q4 2023 | $2,624,859 | -16.2% | 26,317 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $3,131,987 | -34.2% | 26,317 | -8.8% | 0.00% | -50.0% |
Q2 2023 | $4,760,579 | 0.0% | 28,859 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $4,760,579 | -1.8% | 28,859 | -6.3% | 0.00% | -33.3% |
Q4 2022 | $4,849,125 | -99.9% | 30,792 | -1.0% | 0.00% | 0.0% |
Q3 2022 | $4,686,372,000 | -20.0% | 31,118 | -12.6% | 0.00% | 0.0% |
Q2 2022 | $5,854,748,000 | -24.0% | 35,615 | +3.0% | 0.00% | 0.0% |
Q1 2022 | $7,699,559,000 | -5.5% | 34,583 | +0.7% | 0.00% | 0.0% |
Q4 2021 | $8,150,493,000 | +2.6% | 34,341 | +0.9% | 0.00% | 0.0% |
Q3 2021 | $7,944,021,000 | +15.1% | 34,039 | +1.5% | 0.00% | 0.0% |
Q2 2021 | $6,904,589,000 | -0.6% | 33,550 | -0.8% | 0.00% | 0.0% |
Q1 2021 | $6,946,542,000 | -4.0% | 33,813 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $7,233,889,000 | +59.9% | 33,726 | +36.3% | 0.00% | +50.0% |
Q3 2020 | $4,523,127,000 | +2.2% | 24,749 | +3.1% | 0.00% | -33.3% |
Q2 2020 | $4,425,467,000 | -4.6% | 24,011 | +4.4% | 0.00% | 0.0% |
Q1 2020 | $4,641,114,000 | +5.5% | 23,002 | -2.1% | 0.00% | 0.0% |
Q4 2019 | $4,398,256,000 | +22.0% | 23,505 | +4.1% | 0.00% | +50.0% |
Q3 2019 | $3,604,885,000 | -63.2% | 22,587 | -42.0% | 0.00% | -71.4% |
Q2 2019 | $9,802,573,000 | +17.3% | 38,913 | +11.4% | 0.01% | +16.7% |
Q1 2019 | $8,357,164,000 | +54.0% | 34,919 | +47.8% | 0.01% | +20.0% |
Q4 2018 | $5,426,157,000 | +20.1% | 23,630 | +47.9% | 0.01% | +66.7% |
Q3 2018 | $4,518,346,000 | -0.2% | 15,980 | +3.6% | 0.00% | 0.0% |
Q2 2018 | $4,527,789,000 | -25.9% | 15,419 | -36.3% | 0.00% | -40.0% |
Q1 2018 | $6,109,090,000 | -40.0% | 24,204 | -48.7% | 0.01% | -44.4% |
Q4 2017 | $10,188,504,000 | +48.6% | 47,169 | +27.8% | 0.01% | +50.0% |
Q3 2017 | $6,857,492,000 | +28.5% | 36,898 | +19.3% | 0.01% | +20.0% |
Q2 2017 | $5,335,254,000 | +5.6% | 30,929 | -6.5% | 0.01% | 0.0% |
Q1 2017 | $5,053,454,000 | +95284.2% | 33,094 | -8.0% | 0.01% | -16.7% |
Q4 2016 | $5,298,000 | -15.3% | 35,959 | -27.3% | 0.01% | -14.3% |
Q3 2016 | $6,253,000 | +4.0% | 49,481 | -7.2% | 0.01% | 0.0% |
Q2 2016 | $6,010,000 | +8.3% | 53,303 | 0.0% | 0.01% | +16.7% |
Q1 2016 | $5,549,000 | +9.4% | 53,303 | +18.6% | 0.01% | 0.0% |
Q4 2015 | $5,071,000 | +381.6% | 44,962 | +367.7% | 0.01% | +500.0% |
Q3 2015 | $1,053,000 | +66.9% | 9,613 | +45.7% | 0.00% | 0.0% |
Q2 2015 | $631,000 | +4.3% | 6,600 | +1.5% | 0.00% | 0.0% |
Q1 2015 | $605,000 | +19.1% | 6,500 | +4.8% | 0.00% | – |
Q4 2014 | $508,000 | +38.8% | 6,200 | +8.8% | 0.00% | – |
Q3 2014 | $366,000 | +5.5% | 5,700 | 0.0% | 0.00% | – |
Q2 2014 | $347,000 | +1.8% | 5,700 | 0.0% | 0.00% | – |
Q1 2014 | $341,000 | +44.5% | 5,700 | +54.1% | 0.00% | – |
Q4 2013 | $236,000 | +5.4% | 3,700 | +12.1% | 0.00% | – |
Q3 2013 | $224,000 | -88.6% | 3,300 | -87.9% | 0.00% | -100.0% |
Q2 2013 | $1,966,000 | – | 27,279 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sandhill Capital Partners LLC | 91,082 | $20,915,000 | 3.45% |
CROWN ADVISORS MANAGEMENT, INC. | 14,000 | $3,215,000 | 3.34% |
PURA VIDA INVESTMENTS, LLC | 65,119 | $14,953,000 | 2.98% |
Lyon Street Capital, LLC | 11,105 | $2,550,000 | 2.56% |
GW&K Investment Management, LLC | 412,350 | $94,688,000 | 1.87% |
Penn Capital Management Company, LLC | 51,722 | $14,451,000 | 1.43% |
Hotaling Investment Management, LLC | 6,351 | $1,458,000 | 1.19% |
PFM Health Sciences, LP | 175,758 | $40,359,000 | 1.07% |
DIXON HUBARD FEINOUR & BROWN INC/VA | 12,430 | $2,854,000 | 1.06% |
GAM Holding AG | 90,452 | $20,769,000 | 1.05% |